(Q43053396)

13 November 2017

Alterations in the p53 pathway and p16INK4a expression predict overall survival in metastatic melanoma patients treated with dacarbazine (English)

1 reference

13 November 2017

1 reference

5

Per E Lønning

1 reference

13 November 2017

3

Stian Knappskog

1 reference

13 November 2017

2

Jürgen Geisler

1 reference

13 November 2017

Christian Busch

1

1 reference

PubMed ID

20505745

13 November 2017

Johan R Lillehaug

series ordinal

4

1 reference

PubMed ID

20505745

13 November 2017

language of work or name

English

0 references

publication date

27 May 2010

1 reference

Journal of Investigative Dermatology

13 November 2017

1 reference

13 November 2017

130

1 reference

13 November 2017

10

1 reference

13 November 2017

2514-2516

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2010.138

13 November 2017

0 references

cites work

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

Novel biomarkers in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

The pathological response to DNA damage does not contribute to p53-mediated tumour suppression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

p53: guardian of the genome and policeman of the oncogenes.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

Overexpression and mutations of p53 in metastatic malignant melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

The MDM2 gene amplification database

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

Mdm2: keeping p53 under control

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.138

7 January 2021

Identifiers

DOI

10.1038/JID.2010.138

1 reference

13 November 2017

1 reference

PubMed ID

20505745